Decrease in depression, anxiety PTSD at Oregon psilocybin centers

Amid debates about using psychedelics for mental health and substance use disorders, results from a longitudinal cohort study published in JAMA Network Open show that state-regulated psilocybin services appear safe and beneficial.
“When Oregon voters passed a ballot initiative in 2020 to permit state-licensed access to psilocybin services, our group of interdisciplinary researchers talked about the need to learn about the safety and outcomes of this first-in-the-nation initiative,” P. Todd Korthuis, MD, MPH, professor of medicine at the Oregon Health & Science University School of

Emphasize ketone monitoring, action plan in diabetes management

Ketone monitoring is an essential part of type 1 diabetes management, and the availability of a dual glucose and ketone sensor could provide patients with a tool to measure levels more easily, according to a speaker.
As Healio previously reported, the FDA approved the first dual glucose and ketone sensor (Libre Duo 10 Day system, Abbott Diabetes) for children and adults aged 2 years or older with diabetes in August. During a presentation at the Association of Diabetes Care & Education Specialists annual meeting, Christie Beatson, MS, RD, CDCES, senior instructor at the Barbara Davis Center

Dual mobility implants may decrease dislocations rates in THA

Dual mobility total hip replacement may decrease the risk for postoperative joint dislocation in patients 65 years or older, according to results published in The Lancet.
“[Dual mobility] THR is highly effective compared with standard THR in reducing the risk of dislocation, the most common postoperative surgical complication after this procedure, and it is also effective in reducing the risk of other surgical complications,” Nils P. Hailer, MD, and colleagues wrote in the study. “Dual mobility THR, when available, should therefore be considered for patients with a displaced

Memory tests may be limited after breast cancer chemotherapy

Women who received chemotherapy for breast cancer had lower performance in narrative memory tasks and greater cognitive workloads than women with no history of breast cancer, according to data published in Translational Neuroscience.
Yet both groups had similar performance in tasks involving verbal paired associates, indicating limitations in standard memory assessments for breast cancer survivors, Melanie J. Sekeres, PhD, associate professor, school of psychology at the University of Ottawa, and colleagues wrote.
“What really motivated the study is the known impact of chemotherapy on the

Q&A: Digital health innovations can improve posttransplant care

Digital health tools and collaboration with local clinics may help to improve patient care after transplantation, according to experts.
Existing and emerging technologies, including remote patient monitoring and wearable devices, could help to reduce trips to a transplant center after transplantation, according to Richard Knight, MD, FACS, senior director of medical affairs, medical affairs, transplant diagnostics, Thermo Fisher Scientific and Tina Liedtky, president of transplant diagnostics business at Thermo Fisher Scientific.
Healio spoke with Knight and Liedtky about the role of local

Program in Latin America supports patients with rare lung disease

Through a clinic in Mexico, Ricardo A. Mosquera, MD, is helping an underrepresented population in the realm of primary ciliary dyskinesia get diagnosed, treated and involved in rare lung disease research.
Originally from Colombia, Mosquera told Healio this outreach program in Latin America through UTHealth Houston is very important to him and demonstrates the widespread positive impact that comes with helping other countries.
Healio spoke with Mosquera, professor and director of the pulmonary and sleep medicine division at The University of Texas Health Science Center at Houston (UTHealth

Tezepelumab improves dysphagia frequency, severity in EoE

Adolescents and adults with eosinophilic esophagitis receiving tezepelumab vs. placebo had improved frequency and severity of dysphagia and more achievement of histologic remission at week 24, according to phase 3 trial topline results.
“The positive phase 3 CROSSING trial demonstrates that Tezspire could provide a new approach to treating EoE, helping more patients achieve histologic remission and meaningful symptom relief on an every-4-week dosing schedule,” Evan S. Dellon, MD, MPH, professor of medicine and director of the Center for Esophageal Diseases and Swallowing at the University of

Ultra-processed food intake linked to prostate cancer risk

Greater consumption of ultra-processed foods may increase risk for prostate cancer, study findings suggest.
An analysis of self-reported data from a large and representative sample of adult men in the U.S. showed those with higher intake of ultra-processed foods exhibited 24% to 34% greater risk for prostate cancer than those with lower intake.
“The magnitude [and] pattern of risk were generally consistent,” senior author Charles H. Hennekens, MD, FACPM, the first Sir Richard Doll Professor of Medicine & Preventive Medicine at Florida Atlantic University’s Schmidt College of Medicine, told

Three generations of rheumatologists assess a changing field

Published reviews and meeting sessions alike have recently pondered the impending generational shift in rheumatology, as retirements continue to drive ongoing workforce shortages.
However, understanding how each wave of physicians managed treatments, patient expectations and obstacles could offer clues as to what the future holds for the specialty as younger rheumatologists increasingly step up.
Four rheumatologists from three different generations — baby boomer, Gen X and millennial — spoke with Healio about their experiences in training and treatment goals at the outset of their careers vs.